ANGO
AngioDynamics, Inc.
Price Chart
Latest Quote
$11.94
-0.09 (-0.75%)
Current Price
| Previous Close | $12.03 |
| Open | $12.04 |
| Day High | $12.39 |
| Day Low | $11.89 |
| Volume | 385,217 |
Stock Information
| Shares Outstanding | 41.32M |
| Total Debt | $11.39M |
| Cash Equivalents | $37.81M |
| Revenue | $313.72M |
| Net Income | $-31.39M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $493.35M |
| EPS (TTM) | $-0.76 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $471.27M |
| Sales | $313.72M |
| Income | $-31.39M |
| Book/sh | $4.16 |
| Cash/sh | $0.92 |
| Employees | 675 |
Financial Ratios
| Quick Ratio | 1.26 |
| Current Ratio | 2.35 |
| Debt/Eq | 6.57 |
Returns & Margins
| ROA | -4.68% |
| ROE | -17.47% |
| Gross Margin | 54.30% |
| Operating Margin | -8.20% |
| Profit Margin | -10.01% |
Ownership
| Insider Ownership | 12.28% |
| Institutional Ownership | 94.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -54.27 |
| PEG | 1.41 |
| P/S | 1.57 |
| P/B | 2.87 |
Analyst Data
| Recommendation | none |
| Target Price | $18.00 |
Technical Indicators
| SMA20 | $11.39 |
| SMA50 | $11.01 |
| SMA200 | $11.30 |
| RSI | 66.57 |
| ATR | 0.4857 |
| Shares Float | 34.61M |
| Short Float | 5.02% |
| Short Ratio | 5.95 |
| Volatility | 0.36 |
| Rel Volume | 1.24 |
Performance History
| Week | +4.01% |
| Month | +8.05% |
| Quarter | +10.25% |
| 6 Months | -11.49% |
| YTD | -5.84% |
| Year | +8.94% |
| 3 Years | +26.22% |
| 5 Years | -48.36% |
| 10 Years | -5.54% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $11.94 | 385,200 |
| 2026-06-04 | $12.03 | 231,100 |
| 2026-06-03 | $11.20 | 294,800 |
| 2026-06-02 | $10.98 | 284,200 |
| 2026-06-01 | $10.91 | 371,000 |
| 2026-05-29 | $11.48 | 248,500 |
| 2026-05-28 | $11.79 | 331,200 |
| 2026-05-27 | $11.84 | 292,100 |
| 2026-05-26 | $11.80 | 418,800 |
| 2026-05-22 | $11.92 | 211,500 |
| 2026-05-21 | $11.96 | 342,700 |
| 2026-05-20 | $11.81 | 369,000 |
| 2026-05-19 | $11.44 | 360,200 |
| 2026-05-18 | $11.07 | 245,200 |
| 2026-05-15 | $10.77 | 245,900 |
| 2026-05-14 | $11.03 | 288,300 |
| 2026-05-13 | $10.84 | 250,600 |
| 2026-05-12 | $10.90 | 304,800 |
| 2026-05-11 | $10.84 | 452,700 |
| 2026-05-08 | $11.20 | 291,100 |
| 2026-05-07 | $11.27 | 228,400 |
| 2026-05-06 | $11.05 | 264,000 |
About AngioDynamics, Inc.
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.
đ° Latest News
Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?
Zacks âĸ 2026-05-22T13:55:02Z
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
Zacks âĸ 2026-05-19T15:47:00Z
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet
Zacks âĸ 2026-05-06T13:55:03Z
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade
Zacks âĸ 2026-04-20T13:55:03Z
AngioDynamics CEO Touts Debt-Free Turnaround, Auryon Share Gains, NanoKnife Launch at Needham Conf
MarketBeat âĸ 2026-04-15T01:03:37Z
AngioDynamics (ANGO) Loses 5.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks âĸ 2026-04-10T13:35:02Z
AngioDynamics (ANGO) Upgraded to Buy: Here's Why
Zacks âĸ 2026-04-08T16:00:03Z
ANGO Stock Up in Pre-Market Post Q3 Earnings Beat, Gross Margin Down
Zacks âĸ 2026-04-06T16:12:00Z
AngioDynamics Inc (ANGO) Q3 2026 Earnings Call Highlights: Strong Revenue Growth Amid Financial ...
GuruFocus.com âĸ 2026-04-02T19:00:35ZAngioDynamics, Inc. Q3 2026 Earnings Call Summary
Moby âĸ 2026-04-02T16:41:51Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $119,311,000 | $134,552,000 | $152,423,000 | $140,596,000 |
| Cost Of Revenue | $134,793,000 | $149,216,000 | $164,506,000 | $150,487,000 |
| Total Revenue | $292,498,000 | $303,914,000 | $338,752,000 | $316,219,000 |
| Operating Revenue | $292,498,000 | $303,914,000 | $338,752,000 | $316,219,000 |
| Expenses | ||||
| Total Expenses | $316,560,000 | $337,758,000 | $357,431,000 | $334,436,000 |
| Other Income Expense | $-10,948,000 | $-159,408,000 | $-33,056,000 | $-11,044,000 |
| Other Non Operating Income Expenses | $4,944,000 | $-817,000 | $-554,000 | $-790,000 |
| Net Non Operating Interest Income Expense | $978,000 | $1,614,000 | $-2,702,000 | $-688,000 |
| Total Other Finance Cost | $-978,000 | $-1,614,000 | $2,702,000 | $688,000 |
| Operating Expense | $181,767,000 | $188,542,000 | $192,925,000 | $183,949,000 |
| Selling And Marketing Expense | $103,135,000 | $102,818,000 | $104,249,000 | $95,301,000 |
| Interest Expense | - | - | $2,702,000 | $688,000 |
| Interest Expense Non Operating | - | - | $2,702,000 | $688,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Net Interest Income | $978,000 | $1,614,000 | $-2,702,000 | $-688,000 |
| Normalized Income | $-18,116,892 | $-31,784,458 | $-21,131,129 | $-17,457,784 |
| Net Income From Continuing And Discontinued Operation | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Total Operating Income As Reported | $-39,954,000 | $-192,435,000 | $-51,181,000 | $-28,471,000 |
| Net Income Common Stockholders | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Net Income | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Net Income Including Noncontrolling Interests | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Net Income Continuous Operations | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Pretax Income | $-34,032,000 | $-191,638,000 | $-54,437,000 | $-29,949,000 |
| Special Income Charges | $-15,892,000 | $-158,591,000 | $-32,502,000 | $-10,254,000 |
| Operating Income | $-24,062,000 | $-33,844,000 | $-18,679,000 | $-18,217,000 |
| Depreciation Amortization Depletion Income Statement | $10,318,000 | $13,048,000 | $18,790,000 | $19,458,000 |
| Depreciation And Amortization In Income Statement | $10,318,000 | $13,048,000 | $18,790,000 | $19,458,000 |
| Amortization Of Intangibles Income Statement | $10,318,000 | $13,048,000 | $18,790,000 | $19,458,000 |
| Gross Profit | $157,705,000 | $154,698,000 | $174,246,000 | $165,732,000 |
| Net Income Discontinuous Operations | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
| Basic EPS | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
| Other | ||||
| Tax Effect Of Unusual Items | $-15,892 | $-6,026,458 | $-1,191,129 | $-1,164,784 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $17,630,000 | $152,459,000 | $44,696,000 | $21,386,000 |
| Total Unusual Items | $-15,892,000 | $-158,591,000 | $-32,502,000 | $-10,254,000 |
| Total Unusual Items Excluding Goodwill | $-15,892,000 | $-158,591,000 | $-32,502,000 | $-10,254,000 |
| Reconciled Depreciation | $25,800,000 | $27,712,000 | $30,873,000 | $29,349,000 |
| EBITDA (Bullshit earnings) | $1,738,000 | $-6,132,000 | $12,194,000 | $11,132,000 |
| EBIT | $-24,062,000 | $-33,844,000 | $-18,679,000 | $-18,217,000 |
| Diluted Average Shares | $40,853,000 | $40,181,000 | $39,480,000 | $39,009,000 |
| Basic Average Shares | $40,853,000 | $40,181,000 | $39,480,367 | $39,009,000 |
| Diluted NI Availto Com Stockholders | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Tax Provision | $-39,000 | $-7,289,000 | $-1,995,000 | $-3,402,000 |
| Gain On Sale Of Ppe | $0 | $54,499,000 | $0 | $0 |
| Other Special Charges | $715,000 | $34,942,000 | $9,998,000 | $7,625,000 |
| Impairment Of Capital Assets | $0 | $165,736,000 | $14,549,000 | $0 |
| Restructuring And Mergern Acquisition | $15,177,000 | $12,412,000 | $7,955,000 | $2,629,000 |
| Amortization | $10,318,000 | $13,048,000 | $18,790,000 | $19,458,000 |
| Research And Development | $26,222,000 | $31,512,000 | $29,883,000 | $30,739,000 |
| Selling General And Administration | $145,227,000 | $143,982,000 | $144,252,000 | $133,752,000 |
| Other Gand A | $42,092,000 | $41,164,000 | $40,003,000 | $38,451,000 |
| Gain On Sale Of Business | - | - | $0 | $0 |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $113,854,000 | $128,203,000 | $107,914,000 | $71,051,000 |
| Total Assets | $280,144,000 | $317,671,000 | $532,637,000 | $552,751,000 |
| Total Non Current Assets | $111,820,000 | $124,418,000 | $369,095,000 | $409,406,000 |
| Other Non Current Assets | $10,404,000 | $11,369,000 | $54,329,000 | $10,963,000 |
| Goodwill And Other Intangible Assets | $69,116,000 | $77,383,000 | $270,382,000 | $353,438,000 |
| Other Intangible Assets | $69,116,000 | $77,383,000 | $111,144,000 | $152,380,000 |
| Current Assets | $168,324,000 | $193,253,000 | $163,542,000 | $143,345,000 |
| Other Current Assets | $3,072,000 | $2,577,000 | $1,102,000 | $2,201,000 |
| Prepaid Assets | $4,213,000 | $3,993,000 | $3,515,000 | $4,429,000 |
| Inventory | $62,006,000 | $60,616,000 | $55,325,000 | $51,392,000 |
| Receivables | $43,140,000 | $50,011,000 | $52,826,000 | $56,498,000 |
| Other Receivables | $250,000 | $6,401,000 | - | - |
| Accounts Receivable | $42,890,000 | $43,610,000 | $52,826,000 | $52,304,000 |
| Allowance For Doubtful Accounts Receivable | $-2,215,000 | $-2,141,000 | $-2,150,000 | $-1,939,000 |
| Gross Accounts Receivable | $45,105,000 | $45,751,000 | $54,976,000 | $54,243,000 |
| Cash Cash Equivalents And Short Term Investments | $55,893,000 | $76,056,000 | $44,620,000 | $28,825,000 |
| Cash And Cash Equivalents | $55,893,000 | $76,056,000 | $44,620,000 | $28,825,000 |
| Assets Held For Sale Current | - | $0 | $6,154,000 | $0 |
| Taxes Receivable | - | - | $0 | $4,194,000 |
| Debt | ||||
| Total Debt | - | $4,728,000 | $64,579,000 | $33,783,000 |
| Current Debt And Capital Lease Obligation | - | $4,728,000 | $14,761,000 | $8,783,000 |
| Current Debt | - | $4,728,000 | $14,761,000 | $8,783,000 |
| Other Current Borrowings | - | $4,728,000 | $14,761,000 | $8,783,000 |
| Net Debt | - | - | $19,959,000 | $4,958,000 |
| Long Term Debt And Capital Lease Obligation | - | - | $49,818,000 | $25,000,000 |
| Long Term Debt | - | - | $49,818,000 | $25,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $97,174,000 | $112,085,000 | $154,341,000 | $128,262,000 |
| Total Non Current Liabilities Net Minority Interest | $20,977,000 | $20,930,000 | $70,516,000 | $53,938,000 |
| Other Non Current Liabilities | $16,904,000 | $16,078,000 | $7,885,000 | $12,901,000 |
| Non Current Deferred Liabilities | $4,073,000 | $4,852,000 | $12,813,000 | $16,037,000 |
| Non Current Deferred Taxes Liabilities | $4,073,000 | $4,852,000 | $12,813,000 | $16,037,000 |
| Current Liabilities | $76,197,000 | $91,155,000 | $83,825,000 | $74,324,000 |
| Other Current Liabilities | $7,388,000 | $7,578,000 | $2,002,000 | $2,652,000 |
| Current Deferred Liabilities | $374,000 | $0 | - | - |
| Payables And Accrued Expenses | $67,635,000 | $77,363,000 | $66,800,000 | $62,830,000 |
| Payables | $36,063,000 | $44,530,000 | $40,925,000 | $28,797,000 |
| Other Payable | $2,241,000 | $6,259,000 | - | - |
| Total Tax Payable | $531,000 | $520,000 | $480,000 | $750,000 |
| Accounts Payable | $33,291,000 | $37,751,000 | $40,445,000 | $28,047,000 |
| Equity | ||||
| Common Stock Equity | $182,970,000 | $205,586,000 | $378,296,000 | $424,489,000 |
| Total Equity Gross Minority Interest | $182,970,000 | $205,586,000 | $378,296,000 | $424,489,000 |
| Stockholders Equity | $182,970,000 | $205,586,000 | $378,296,000 | $424,489,000 |
| Gains Losses Not Affecting Retained Earnings | $-2,023,000 | $-4,365,000 | $-4,723,000 | $1,357,000 |
| Other Equity Adjustments | $-2,023,000 | $-4,365,000 | $-4,723,000 | $1,357,000 |
| Retained Earnings | $-429,197,000 | $-395,204,000 | $-210,855,000 | $-158,413,000 |
| Other | ||||
| Treasury Shares Number | $613,847 | $370,000 | $370,000 | $370,000 |
| Ordinary Shares Number | $40,994,030 | $40,431,597 | $39,611,422 | $39,171,173 |
| Share Issued | $41,607,877 | $40,801,597 | $39,981,422 | $39,541,173 |
| Tangible Book Value | $113,854,000 | $128,203,000 | $107,914,000 | $71,051,000 |
| Invested Capital | $182,970,000 | $210,314,000 | $442,875,000 | $458,272,000 |
| Working Capital | $92,127,000 | $102,098,000 | $79,717,000 | $69,021,000 |
| Total Capitalization | $182,970,000 | $205,586,000 | $428,114,000 | $449,489,000 |
| Treasury Stock | $7,381,000 | $5,714,000 | $5,714,000 | $5,714,000 |
| Additional Paid In Capital | $621,186,000 | $610,484,000 | $599,206,000 | $586,879,000 |
| Capital Stock | $385,000 | $385,000 | $382,000 | $380,000 |
| Common Stock | $385,000 | $385,000 | $382,000 | $380,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $800,000 | $1,486,000 | $262,000 | $59,000 |
| Current Accrued Expenses | $31,572,000 | $32,833,000 | $25,875,000 | $34,033,000 |
| Net PPE | $32,300,000 | $35,666,000 | $44,384,000 | $45,005,000 |
| Accumulated Depreciation | $-71,116,000 | $-73,039,000 | $-59,026,000 | $-51,069,000 |
| Gross PPE | $103,416,000 | $108,705,000 | $103,410,000 | $96,074,000 |
| Construction In Progress | $3,794,000 | $2,638,000 | $2,444,000 | $2,402,000 |
| Other Properties | $36,991,000 | $31,312,000 | $26,355,000 | $21,009,000 |
| Machinery Furniture Equipment | $45,634,000 | $44,163,000 | $44,458,000 | $42,745,000 |
| Buildings And Improvements | $16,604,000 | $30,099,000 | $29,660,000 | $29,425,000 |
| Land And Improvements | $393,000 | $493,000 | $493,000 | $493,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $27,000,000 | $23,108,000 | $19,938,000 | $15,955,000 |
| Work In Process | $7,509,000 | $6,772,000 | $6,708,000 | $7,186,000 |
| Raw Materials | $27,497,000 | $30,736,000 | $28,679,000 | $28,251,000 |
| Goodwill | - | $0 | $159,238,000 | $201,058,000 |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-14,592,000 | $-33,926,000 | $-4,274,000 | $-11,491,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-10,128,000 | $-28,158,000 | $78,000 | $-7,194,000 |
| Cash Flow From Continuing Operating Activities | $-10,128,000 | $-28,158,000 | $78,000 | $-7,194,000 |
| Operating Gains Losses | - | $-54,499,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-4,464,000 | $-5,768,000 | $-4,352,000 | $-4,297,000 |
| Investing Cash Flow | $-10,178,000 | $123,717,000 | $-9,746,000 | $-19,307,000 |
| Cash Flow From Continuing Investing Activities | $-10,178,000 | $123,717,000 | $-9,746,000 | $-19,307,000 |
| Net Other Investing Changes | $-5,714,000 | $129,485,000 | $-5,394,000 | $-11,410,000 |
| Cash From Discontinued Investing Activities | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-1,670,000 | $0 | $0 | - |
| Financing Cash Flow | $-255,000 | $-64,248,000 | $25,420,000 | $7,683,000 |
| Cash Flow From Continuing Financing Activities | $-255,000 | $-64,248,000 | $25,420,000 | $7,683,000 |
| Net Other Financing Charges | $482,000 | $-15,000,000 | $-751,000 | - |
| Net Common Stock Issuance | $-1,670,000 | $0 | $0 | - |
| Other | ||||
| Repayment Of Debt | $0 | $-50,000,000 | $-45,000,000 | $0 |
| Issuance Of Debt | $0 | $0 | $70,000,000 | $5,000,000 |
| Interest Paid Supplemental Data | $185,000 | $0 | $2,577,000 | $562,000 |
| Income Tax Paid Supplemental Data | $800,000 | $455,000 | $342,000 | $329,000 |
| End Cash Position | $55,893,000 | $76,056,000 | $44,620,000 | $28,825,000 |
| Beginning Cash Position | $76,056,000 | $44,620,000 | $28,825,000 | $48,161,000 |
| Effect Of Exchange Rate Changes | $398,000 | $125,000 | $43,000 | $-518,000 |
| Changes In Cash | $-20,561,000 | $31,311,000 | $15,752,000 | $-18,818,000 |
| Proceeds From Stock Option Exercised | $933,000 | $752,000 | $1,171,000 | $2,683,000 |
| Common Stock Payments | $-1,670,000 | $0 | $0 | - |
| Net Issuance Payments Of Debt | $0 | $-50,000,000 | $25,000,000 | $5,000,000 |
| Net Long Term Debt Issuance | $0 | $-50,000,000 | $25,000,000 | $5,000,000 |
| Long Term Debt Payments | $0 | $-50,000,000 | $-45,000,000 | $0 |
| Long Term Debt Issuance | $0 | $0 | $70,000,000 | $5,000,000 |
| Net Intangibles Purchase And Sale | $0 | $-3,250,000 | $-540,000 | $0 |
| Purchase Of Intangibles | $0 | $-3,250,000 | $-540,000 | $0 |
| Net PPE Purchase And Sale | $-4,464,000 | $-2,518,000 | $-3,812,000 | $-4,297,000 |
| Purchase Of PPE | $-4,464,000 | $-2,518,000 | $-3,812,000 | $-4,297,000 |
| Change In Working Capital | $-14,112,000 | $14,421,000 | $-7,026,000 | $-21,047,000 |
| Change In Payables And Accrued Expense | $-15,877,000 | $27,531,000 | $2,139,000 | $3,912,000 |
| Change In Payable | $-15,877,000 | $27,531,000 | $2,139,000 | $3,912,000 |
| Change In Account Payable | $-15,877,000 | $27,531,000 | $2,139,000 | $3,912,000 |
| Change In Prepaid Assets | $3,089,000 | $-11,594,000 | $332,000 | $-5,012,000 |
| Change In Inventory | $-1,347,000 | $-9,410,000 | $-8,198,000 | $-2,796,000 |
| Change In Receivables | $23,000 | $7,894,000 | $-1,299,000 | $-17,151,000 |
| Changes In Account Receivables | $23,000 | $7,894,000 | $-1,299,000 | $-17,151,000 |
| Other Non Cash Items | $2,521,000 | $-2,783,000 | $4,291,000 | $3,558,000 |
| Stock Based Compensation | $9,772,000 | $10,529,000 | $11,158,000 | $10,692,000 |
| Provisionand Write Offof Assets | $699,000 | $1,326,000 | $695,000 | $118,000 |
| Asset Impairment Charge | $173,000 | $167,453,000 | $14,840,000 | $391,000 |
| Deferred Tax | $-988,000 | $-7,968,000 | $-2,311,000 | $-3,708,000 |
| Deferred Income Tax | $-988,000 | $-7,968,000 | $-2,311,000 | $-3,708,000 |
| Depreciation Amortization Depletion | $25,800,000 | $27,712,000 | $30,873,000 | $29,349,000 |
| Depreciation And Amortization | $25,800,000 | $27,712,000 | $30,873,000 | $29,349,000 |
| Net Income From Continuing Operations | $-33,993,000 | $-184,349,000 | $-52,442,000 | $-26,547,000 |
| Net Business Purchase And Sale | - | $0 | $0 | $-3,600,000 |
| Purchase Of Business | - | $0 | $0 | $-3,600,000 |
| Net Investment Purchase And Sale | - | - | - | - |
| Sale Of Investment | - | - | - | - |
Fetched: 2026-06-02